1. Lead compounds with the potentials for the treatment of chronic liver diseases
   Devaraj Ezhilarasan, 2020, Phytochemicals as Lead Compounds for New Drug Discovery CrossRef
2. Ethanolic Leaf Extract of Ocimum gratissimum Abrogates Methotrexate-induced Liver Injury in Albino Rats
   Elias Adikwu et al, 2020, Asian Journal of Biological Sciences CrossRef
3. Combined carvacrol and cilostazol ameliorate ethanol-induced liver fibrosis in rats: Possible role of SIRT1/Nrf2/HO-1 pathway
   Sally E. Abu-Risha et al, 2023, International Immunopharmacology CrossRef
4. Epigallocatechin-3-gallate prevents cardiac apoptosis by modulating the intrinsic apoptotic pathway in isoproterenol-induced myocardial infarction
   Azza I. Othman et al, 2017, European Journal of Pharmacology CrossRef
5. Pomegranate action in curbing the incidence of liver injury triggered by Diethylnitrosamine by declining oxidative stress via Nrf2 and NFκB regulation
   Hadiya Husain et al, 2018, Scientific Reports CrossRef
6. Ameliorative Influence of Green Tea Extract on Copper Nanoparticle-Induced Hepatotoxicity in Rats
   Marwa A. Ibrahim et al, 2015, Nanoscale Research Letters CrossRef
7. Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent Hepatic Fibrosis
   M. L. Arffa et al, 2016, PLOS ONE CrossRef
8. Starch-Based Hydrogel Nanoparticles Loaded with Polyphenolic Compounds of Moringa Oleifera Leaf Extract Have Hepatoprotective Activity in Bisphenol A-Induced Animal Models
   Hend Mohamed Hasanin Abou El-Naga et al, 2022, Polymers CrossRef
9. The effect of Alnus incana (L.) Moench extracts in ameliorating iron overload-induced hepatotoxicity in male albino rats
   Fatma Abo-Elghiet et al, 2023, Scientific Reports CrossRef
10. Protective effects of seed melon extract on CCl4-induced hepatic fibrosis in mice
    Yuan-Yuan Zhan et al, 2016, Journal of Ethnopharmacology CrossRef
11. Nutraceuticals in hepatic diseases
    Sharon M. Gwaltney-Brant, 2021, Nutraceuticals CrossRef
12. Nutraceuticals in Hepatic Diseases
    Sharon M. Gwaltney-Brant, 2016, Nutraceuticals CrossRef
13. A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE
    Asif Zaman et al, 2019, PLOS ONE CrossRef
14. Antifibrotic effect of diethylcarbamazine combined with hesperidin against ethanol induced liver fibrosis in rats
    Alaa El-Din El-Sayed El-Sisi et al, 2017, Biomedicine & Pharmacotherapy CrossRef
15. Betaine treatment decreased oxidative stress, inflammation, and stellate cell activation in rats with alcoholic liver fibrosis
    İlknur Bingül et al, 2016, Environmental Toxicology and Pharmacology CrossRef
16. Starch based hydrogel NPs loaded by anthocyanins might treat glycogen storage at cardiomyopathy in animal fibrotic model
    Nemany A.N. Hanafy, 2021, International Journal of Biological Macromolecules CrossRef
17. Interleukin-13 is involved in the formation of liver fibrosis in Clonorchis sinensis-infected mice
    Yanquan Xu et al, 2016, Parasitology Research CrossRef
18. MiR-155 aggravated septic liver injury by oxidative stress-mediated ER stress and mitochondrial dysfunction via targeting Nrf-2
    Zhao-Bin Yang et al, 2018, Experimental and Molecular Pathology CrossRef
19. Histopathological and Molecular Signatures of a Mouse Model of Acute-on-Chronic Alcoholic Liver Injury Demonstrate Concordance With Human Alcoholic Hepatitis
    Shinji Furuya et al, 2019, Toxicological Sciences CrossRef